- BioMarin Pharmaceutical (BMRN) on Thursday said that it priced its previously announced offering of $850 million of 5.500% senior unsecured notes due 2034 at par.
- The offering is expected to close on February 12, 2026, subject to the satisfaction of customary closing
BioMarin prices $850M senior notes, completes $2B term loan syndication
